VIP and amyotrophic lateral sclerosis: In ALS patients, VIP levels were found decreased in cerebrospinal fluid (CSF) while PACAP and PAC1 receptor had an altered expression in the motor cortex (Werdelin et al., 1989; Bonaventura et al., 2018).